Cargando…

A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator

Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding)...

Descripción completa

Detalles Bibliográficos
Autores principales: Athukoralage, Januka S., Graham, Shirley, Grüschow, Sabine, Rouillon, Christophe, White, Malcolm F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599890/
https://www.ncbi.nlm.nih.gov/pubmed/31071326
http://dx.doi.org/10.1016/j.jmb.2019.04.041
_version_ 1783431006842257408
author Athukoralage, Januka S.
Graham, Shirley
Grüschow, Sabine
Rouillon, Christophe
White, Malcolm F.
author_facet Athukoralage, Januka S.
Graham, Shirley
Grüschow, Sabine
Rouillon, Christophe
White, Malcolm F.
author_sort Athukoralage, Januka S.
collection PubMed
description Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA(4) (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterized protein TTHB144 is a cA(4)-activated HEPN ribonuclease that also degrades its activator. TTHB144 binds and degrades cA(4) at an N-terminal CARF (CRISPR-associated Rossman fold) domain. The two activities can be separated by site-directed mutagenesis. TTHB144 is thus the first example of a self-limiting CRISPR ribonuclease.
format Online
Article
Text
id pubmed-6599890
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-65998902019-07-12 A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator Athukoralage, Januka S. Graham, Shirley Grüschow, Sabine Rouillon, Christophe White, Malcolm F. J Mol Biol Article Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA(4) (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterized protein TTHB144 is a cA(4)-activated HEPN ribonuclease that also degrades its activator. TTHB144 binds and degrades cA(4) at an N-terminal CARF (CRISPR-associated Rossman fold) domain. The two activities can be separated by site-directed mutagenesis. TTHB144 is thus the first example of a self-limiting CRISPR ribonuclease. Elsevier 2019-07-12 /pmc/articles/PMC6599890/ /pubmed/31071326 http://dx.doi.org/10.1016/j.jmb.2019.04.041 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Athukoralage, Januka S.
Graham, Shirley
Grüschow, Sabine
Rouillon, Christophe
White, Malcolm F.
A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title_full A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title_fullStr A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title_full_unstemmed A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title_short A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator
title_sort type iii crispr ancillary ribonuclease degrades its cyclic oligoadenylate activator
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599890/
https://www.ncbi.nlm.nih.gov/pubmed/31071326
http://dx.doi.org/10.1016/j.jmb.2019.04.041
work_keys_str_mv AT athukoralagejanukas atypeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT grahamshirley atypeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT gruschowsabine atypeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT rouillonchristophe atypeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT whitemalcolmf atypeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT athukoralagejanukas typeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT grahamshirley typeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT gruschowsabine typeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT rouillonchristophe typeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator
AT whitemalcolmf typeiiicrisprancillaryribonucleasedegradesitscyclicoligoadenylateactivator